-
1
-
-
0023748414
-
Genetic alterations during colorectal-tumor development
-
Vogelstein B, Fearon ER, Hamilton SR. Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-32.
-
(1988)
N Engl J Med
, vol.319
, pp. 525-532
-
-
Vogelstein, B.1
Fearon, E.R.2
Hamilton, S.R.3
-
2
-
-
0027954225
-
C-met mRNA overexpression in human hepatocellular carcinoma
-
Boix L, Rosa JL, Ventura F. c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology 1994, 19:88-91.
-
(1994)
Hepatology
, vol.19
, pp. 88-91
-
-
Boix, L.1
Rosa, J.L.2
Ventura, F.3
-
3
-
-
0025367299
-
The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors
-
Zhang XK, Huang DP, Qiu DK, Chiu JF. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 1990, 5:909-14.
-
(1990)
Oncogene
, vol.5
, pp. 909-914
-
-
Zhang, X.K.1
Huang, D.P.2
Qiu, D.K.3
Chiu, J.F.4
-
4
-
-
0028023861
-
Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma
-
Zhang X, Xu HJ, Murakami Y. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994, 54:4177-82.
-
(1994)
Cancer Res
, vol.54
, pp. 4177-4182
-
-
Zhang, X.1
Xu, H.J.2
Murakami, Y.3
-
5
-
-
0030928653
-
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
-
Yamada T, De Souza AT, Finkelstein S, Jirtle RL. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997, 94:10351-5.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 10351-10355
-
-
Yamada, T.1
De Souza, A.T.2
Finkelstein, S.3
Jirtle, R.L.4
-
6
-
-
0028292294
-
Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
-
Nishida N, Fukuda Y, Komeda T. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994, 54:3107-10.
-
(1994)
Cancer Res
, vol.54
, pp. 3107-3110
-
-
Nishida, N.1
Fukuda, Y.2
Komeda, T.3
-
7
-
-
0034495080
-
Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
-
Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 2000, 157:763-70.
-
(2000)
Am J Pathol
, vol.157
, pp. 763-770
-
-
Hsu, H.C.1
Jeng, Y.M.2
Mao, T.L.3
Chu, J.S.4
Lai, P.L.5
Peng, S.Y.6
-
8
-
-
0025732215
-
Mutational hotspot in the p53 gene in human hepatocellular carcinomas
-
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991, 350:427-8.
-
(1991)
Nature
, vol.350
, pp. 427-428
-
-
Hsu, I.C.1
Metcalf, R.A.2
Sun, T.3
Welsh, J.A.4
Wang, N.J.5
Harris, C.C.6
-
9
-
-
0031854097
-
Breast cancer biology blossoms in the clinic
-
Nass SJ, Hahm HA, Davidson NE. Breast cancer biology blossoms in the clinic. Nat Med 1998, 4:761-2.
-
(1998)
Nat Med
, vol.4
, pp. 761-762
-
-
Nass, S.J.1
Hahm, H.A.2
Davidson, N.E.3
-
10
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-42.
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
11
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
Lynch TJ, Bell DW, Sordella R. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-39.
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
12
-
-
34247611828
-
Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges
-
Midorikawa Y, Makuuchi M, Tang W, Aburatani H. Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. World J Gastroenterol 2007, 13:1487-92.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 1487-1492
-
-
Midorikawa, Y.1
Makuuchi, M.2
Tang, W.3
Aburatani, H.4
-
13
-
-
9344229795
-
Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma
-
Cheung ST, Wong SY, Leung KL. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 2004, 10:7629-36.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7629-7636
-
-
Cheung, S.T.1
Wong, S.Y.2
Leung, K.L.3
-
14
-
-
43949142502
-
Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma
-
Ho JC, Ip YC, Cheung ST. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology 2008, 47:1524-32.
-
(2008)
Hepatology
, vol.47
, pp. 1524-1532
-
-
Ho, J.C.1
Ip, Y.C.2
Cheung, S.T.3
-
15
-
-
57149085273
-
Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer
-
Ishiguro T, Sugimoto M, Kinoshita Y. Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res 2008, 68:9832-8.
-
(2008)
Cancer Res
, vol.68
, pp. 9832-9838
-
-
Ishiguro, T.1
Sugimoto, M.2
Kinoshita, Y.3
-
16
-
-
57049157619
-
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
-
Nakano K, Orita T, Nezu J. Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2009, 378:279-84.
-
(2009)
Biochem Biophys Res Commun
, vol.378
, pp. 279-284
-
-
Nakano, K.1
Orita, T.2
Nezu, J.3
-
17
-
-
33745212839
-
Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target
-
Ito H, Funahashi S, Yamauchi N. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin Cancer Res 2006, 12:3257-64.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 3257-3264
-
-
Ito, H.1
Funahashi, S.2
Yamauchi, N.3
-
18
-
-
34848881905
-
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
-
Calvisi DF, Ladu S, Gorden A. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007, 117:2713-22.
-
(2007)
J Clin Invest
, vol.117
, pp. 2713-2722
-
-
Calvisi, D.F.1
Ladu, S.2
Gorden, A.3
-
20
-
-
53049086329
-
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
-
Chiang DY, Villanueva A, Hoshida Y. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008, 68:6779-88.
-
(2008)
Cancer Res
, vol.68
, pp. 6779-6788
-
-
Chiang, D.Y.1
Villanueva, A.2
Hoshida, Y.3
-
21
-
-
33846212284
-
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
-
Liu L, Cao Y, Chen C. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006, 66:11851-8.
-
(2006)
Cancer Res
, vol.66
, pp. 11851-11858
-
-
Liu, L.1
Cao, Y.2
Chen, C.3
-
22
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-90.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
-
23
-
-
38049080992
-
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma
-
Zhu AX. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. Cancer 2008, 112:250-9.
-
(2008)
Cancer
, vol.112
, pp. 250-259
-
-
Zhu, A.X.1
-
24
-
-
67651165187
-
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
-
Epub ahead of print
-
Faivre S, Raymond E, Boucher E. Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. Lancet Oncol 2009, Epub ahead of print
-
(2009)
Lancet Oncol
-
-
Faivre, S.1
Raymond, E.2
Boucher, E.3
-
25
-
-
46449091500
-
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
-
Siegel AB, Cohen EI, Ocean A. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol 2008, 26:2992-8.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2992-2998
-
-
Siegel, A.B.1
Cohen, E.I.2
Ocean, A.3
-
26
-
-
60849124241
-
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma
-
Thomas MB, Morris JS, Chadha R. Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol 2009, 27:843-50.
-
(2009)
J Clin Oncol
, vol.27
, pp. 843-850
-
-
Thomas, M.B.1
Morris, J.S.2
Chadha, R.3
-
27
-
-
33646351795
-
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
-
Zhu AX, Blaszkowsky LS, Ryan DP. Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma. J Clin Oncol 2006, 24:1898-903.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1898-1903
-
-
Zhu, A.X.1
Blaszkowsky, L.S.2
Ryan, D.P.3
-
28
-
-
34447326697
-
Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer
-
Stock P, Monga D, Tan X, Micsenyi A, Loizos N, Monga SP. Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer. Mol Cancer Ther 2007, 6:1932-41.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 1932-1941
-
-
Stock, P.1
Monga, D.2
Tan, X.3
Micsenyi, A.4
Loizos, N.5
Monga, S.P.6
-
29
-
-
20144389471
-
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target
-
Loizos N, Xu Y, Huber J. Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target. Mol Cancer Ther 2005, 4:369-79.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 369-379
-
-
Loizos, N.1
Xu, Y.2
Huber, J.3
-
30
-
-
29144474459
-
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma
-
Eckel F, von Delius S, Mayr M. Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology 2005, 69:363-71.
-
(2005)
Oncology
, vol.69
, pp. 363-371
-
-
Eckel, F.1
von Delius, S.2
Mayr, M.3
-
31
-
-
42449109133
-
Phase II study of imatinib in unresectable hepatocellular carcinoma
-
Lin AY, Fisher GA, So S, Tang C, Levitt L. Phase II study of imatinib in unresectable hepatocellular carcinoma. Am J Clin Oncol 2008, 31:84-8.
-
(2008)
Am J Clin Oncol
, vol.31
, pp. 84-88
-
-
Lin, A.Y.1
Fisher, G.A.2
So, S.3
Tang, C.4
Levitt, L.5
-
32
-
-
0031937366
-
Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis
-
Thoresen GH, Guren TK, Sandnes D, Peak M, Agius L, Christoffersen T. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. J Cell Physiol 1998, 175:10-18.
-
(1998)
J Cell Physiol
, vol.175
, pp. 10-18
-
-
Thoresen, G.H.1
Guren, T.K.2
Sandnes, D.3
Peak, M.4
Agius, L.5
Christoffersen, T.6
-
33
-
-
42049116522
-
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
-
Fuchs BC, Fujii T, Dorfman JD. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 2008, 68:2391-9.
-
(2008)
Cancer Res
, vol.68
, pp. 2391-2399
-
-
Fuchs, B.C.1
Fujii, T.2
Dorfman, J.D.3
-
34
-
-
9644255742
-
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
-
Hopfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, Scherubl H. Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. J Hepatol 2004, 41:1008-16.
-
(2004)
J Hepatol
, vol.41
, pp. 1008-1016
-
-
Hopfner, M.1
Sutter, A.P.2
Huether, A.3
Schuppan, D.4
Zeitz, M.5
Scherubl, H.6
-
35
-
-
33744903661
-
PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib
-
Ueda S, Basaki Y, Yoshie M. PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib. Cancer Res 2006, 66:5346-53.
-
(2006)
Cancer Res
, vol.66
, pp. 5346-5353
-
-
Ueda, S.1
Basaki, Y.2
Yoshie, M.3
-
36
-
-
19944432263
-
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
-
Schiffer E, Housset C, Cacheux W. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005, 41:307-14.
-
(2005)
Hepatology
, vol.41
, pp. 307-314
-
-
Schiffer, E.1
Housset, C.2
Cacheux, W.3
-
37
-
-
27244447373
-
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer
-
Philip PA, Mahoney MR, Allmer C. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol 2005, 23:6657-63.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6657-6663
-
-
Philip, P.A.1
Mahoney, M.R.2
Allmer, C.3
-
38
-
-
34548150925
-
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
-
Thomas MB, Chadha R, Glover K. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer 2007, 110:1059-67.
-
(2007)
Cancer
, vol.110
, pp. 1059-1067
-
-
Thomas, M.B.1
Chadha, R.2
Glover, K.3
-
39
-
-
34547102484
-
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
-
Zhu AX, Stuart K, Blaszkowsky LS. Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma. Cancer 2007, 110:581-9.
-
(2007)
Cancer
, vol.110
, pp. 581-589
-
-
Zhu, A.X.1
Stuart, K.2
Blaszkowsky, L.S.3
-
40
-
-
46049097410
-
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study
-
Asnacios A, Fartoux L, Romano O. Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study. Cancer 2008, 112:2733-9.
-
(2008)
Cancer
, vol.112
, pp. 2733-2739
-
-
Asnacios, A.1
Fartoux, L.2
Romano, O.3
-
41
-
-
0030951358
-
Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma
-
Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology 1997, 25:619-23.
-
(1997)
Hepatology
, vol.25
, pp. 619-623
-
-
Ueki, T.1
Fujimoto, J.2
Suzuki, T.3
Yamamoto, H.4
Okamoto, E.5
-
42
-
-
33748421506
-
Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays
-
Midorikawa Y, Yamamoto S, Ishikawa S. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 2006, 25:5581-90.
-
(2006)
Oncogene
, vol.25
, pp. 5581-5590
-
-
Midorikawa, Y.1
Yamamoto, S.2
Ishikawa, S.3
-
43
-
-
38949159306
-
Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target
-
Lee KH, Choi EY, Hyun MS. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target. Clin Exp Metastasis 2008, 25:89-96.
-
(2008)
Clin Exp Metastasis
, vol.25
, pp. 89-96
-
-
Lee, K.H.1
Choi, E.Y.2
Hyun, M.S.3
-
44
-
-
0035947770
-
Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice
-
Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 2001, 153:1023-34.
-
(2001)
J Cell Biol
, vol.153
, pp. 1023-1034
-
-
Wang, R.1
Ferrell, L.D.2
Faouzi, S.3
Maher, J.J.4
Bishop, J.M.5
-
45
-
-
35148864569
-
In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells
-
Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells. Int J Oncol 2007, 31:451-60.
-
(2007)
Int J Oncol
, vol.31
, pp. 451-460
-
-
Salvi, A.1
Arici, B.2
Portolani, N.3
Giulini, S.M.4
De Petro, G.5
Barlati, S.6
-
46
-
-
4444363661
-
SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells
-
Wang SY, Chen B, Zhan YQ. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells. J Hepatol 2004, 41:267-73.
-
(2004)
J Hepatol
, vol.41
, pp. 267-273
-
-
Wang, S.Y.1
Chen, B.2
Zhan, Y.Q.3
-
47
-
-
32044466838
-
Exploiting the PI3K/AKT pathway for cancer drug discovery
-
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005, 4:988-1004.
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 988-1004
-
-
Hennessy, B.T.1
Smith, D.L.2
Ram, P.T.3
Lu, Y.4
Mills, G.B.5
-
48
-
-
57349087153
-
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
-
Villanueva A, Chiang DY, Newell P. Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma. Gastroenterology 2008, 135:1972-83.
-
(2008)
Gastroenterology
, vol.135
, pp. 1972-1983
-
-
Villanueva, A.1
Chiang, D.Y.2
Newell, P.3
-
49
-
-
55549129243
-
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
-
Jasinghe VJ, Xie Z, Zhou J. ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft. J Hepatol 2008, 49:985-97.
-
(2008)
J Hepatol
, vol.49
, pp. 985-997
-
-
Jasinghe, V.J.1
Xie, Z.2
Zhou, J.3
-
50
-
-
52649085241
-
Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma
-
Wang Z, Zhou J, Fan J. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 2008, 14:5124-30.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5124-5130
-
-
Wang, Z.1
Zhou, J.2
Fan, J.3
-
51
-
-
33745634379
-
Activation of the hedgehog pathway in human hepatocellular carcinomas
-
Huang S, He J, Zhang X. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 2006, 27:1334-40.
-
(2006)
Carcinogenesis
, vol.27
, pp. 1334-1340
-
-
Huang, S.1
He, J.2
Zhang, X.3
-
52
-
-
32544437230
-
Hedgehog signaling in human hepatocellular carcinoma
-
Patil MA, Zhang J, Ho C, Cheung ST, Fan ST, Chen X. Hedgehog signaling in human hepatocellular carcinoma. Cancer Biol Ther 2006, 5:111-17.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 111-117
-
-
Patil, M.A.1
Zhang, J.2
Ho, C.3
Cheung, S.T.4
Fan, S.T.5
Chen, X.6
-
53
-
-
41849105045
-
Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma
-
Breuhahn K, Schirmacher P. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J Gastroenterol 2008, 14:1690-8.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 1690-1698
-
-
Breuhahn, K.1
Schirmacher, P.2
-
54
-
-
47149111583
-
Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis
-
Nussbaum T, Samarin J, Ehemann V. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. Hepatology 2008, 48:146-56.
-
(2008)
Hepatology
, vol.48
, pp. 146-156
-
-
Nussbaum, T.1
Samarin, J.2
Ehemann, V.3
-
55
-
-
0036327424
-
Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis
-
Midorikawa Y, Tsutsumi S, Taniguchi H. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J Cancer Res 2002, 93:636-43.
-
(2002)
Jpn J Cancer Res
, vol.93
, pp. 636-643
-
-
Midorikawa, Y.1
Tsutsumi, S.2
Taniguchi, H.3
-
56
-
-
0033648033
-
Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis
-
Lau WY, Lai PB, Leung MF. Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol Res 2000, 12:59-69.
-
(2000)
Oncol Res
, vol.12
, pp. 59-69
-
-
Lau, W.Y.1
Lai, P.B.2
Leung, M.F.3
-
57
-
-
0037099610
-
Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method
-
Iizuka N, Oka M, Yamada-Okabe H. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002, 62:3939-44.
-
(2002)
Cancer Res
, vol.62
, pp. 3939-3944
-
-
Iizuka, N.1
Oka, M.2
Yamada-Okabe, H.3
-
58
-
-
0035266345
-
Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression
-
Okabe H, Satoh S, Kato T. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001, 61:2129-37.
-
(2001)
Cancer Res
, vol.61
, pp. 2129-2137
-
-
Okabe, H.1
Satoh, S.2
Kato, T.3
-
59
-
-
0035088412
-
Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays
-
Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001, 33:832-40.
-
(2001)
Hepatology
, vol.33
, pp. 832-840
-
-
Shirota, Y.1
Kaneko, S.2
Honda, M.3
Kawai, H.F.4
Kobayashi, K.5
-
60
-
-
0035910064
-
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver
-
Xu XR, Huang J, Xu ZG. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001, 98:15089-94.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 15089-15094
-
-
Xu, X.R.1
Huang, J.2
Xu, Z.G.3
-
61
-
-
47149113604
-
Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
-
Nakata T, Seki N, Miwa S. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis? Hepatogastroenterology 2008, 55:865-72.
-
(2008)
Hepatogastroenterology
, vol.55
, pp. 865-872
-
-
Nakata, T.1
Seki, N.2
Miwa, S.3
-
62
-
-
58149280832
-
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance
-
Wong N, Yeo W, Wong WL. TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer 2009, 124:644-52.
-
(2009)
Int J Cancer
, vol.124
, pp. 644-652
-
-
Wong, N.1
Yeo, W.2
Wong, W.L.3
-
63
-
-
52149109119
-
Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma
-
Epub ahead of print
-
Liao YL, Sun YM, Chau GY. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 2008, Epub ahead of print
-
(2008)
Oncogene
-
-
Liao, Y.L.1
Sun, Y.M.2
Chau, G.Y.3
-
64
-
-
60449087921
-
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features
-
Yamashita T, Ji J, Budhu A. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-24.
-
(2009)
Gastroenterology
, vol.136
, pp. 1012-1024
-
-
Yamashita, T.1
Ji, J.2
Budhu, A.3
-
65
-
-
43549115722
-
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
-
Tanaka S, Arii S, Yasen M. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy. Br J Surg 2008, 95:611-19.
-
(2008)
Br J Surg
, vol.95
, pp. 611-619
-
-
Tanaka, S.1
Arii, S.2
Yasen, M.3
-
66
-
-
39749097885
-
Identification of cystatin B as a potential serum marker in hepatocellular carcinoma
-
Lee MJ, Yu GR, Park SH. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma. Clin Cancer Res 2008, 14:1080-9.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1080-1089
-
-
Lee, M.J.1
Yu, G.R.2
Park, S.H.3
-
67
-
-
34247549347
-
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
-
Wurmbach E, Chen YB, Khitrov G. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007, 45:938-47.
-
(2007)
Hepatology
, vol.45
, pp. 938-947
-
-
Wurmbach, E.1
Chen, Y.B.2
Khitrov, G.3
-
68
-
-
57349090407
-
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
-
Hoshida Y, Villanueva A, Kobayashi M. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008, 359:1995-2004.
-
(2008)
N Engl J Med
, vol.359
, pp. 1995-2004
-
-
Hoshida, Y.1
Villanueva, A.2
Kobayashi, M.3
-
69
-
-
34250866207
-
FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway
-
Chen CH, Lu PJ, Chen YC. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene 2007, 26:4272-83.
-
(2007)
Oncogene
, vol.26
, pp. 4272-4283
-
-
Chen, C.H.1
Lu, P.J.2
Chen, Y.C.3
-
70
-
-
57749191742
-
The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells
-
Arai M, Kondoh N, Imazeki N. The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells. Liver Int 2009, 29:55-62.
-
(2009)
Liver Int
, vol.29
, pp. 55-62
-
-
Arai, M.1
Kondoh, N.2
Imazeki, N.3
-
71
-
-
33747350006
-
TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas
-
Silva FP, Hamamoto R, Furukawa Y, Nakamura Y. TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas. Oncogene 2006, 25:5063-70.
-
(2006)
Oncogene
, vol.25
, pp. 5063-5070
-
-
Silva, F.P.1
Hamamoto, R.2
Furukawa, Y.3
Nakamura, Y.4
-
72
-
-
3843065717
-
Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas
-
Okabe H, Furukawa Y, Kato T, Hasegawa S, Yamaoka Y, Nakamura Y. Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas. Int J Oncol 2004, 24:43-8.
-
(2004)
Int J Oncol
, vol.24
, pp. 43-48
-
-
Okabe, H.1
Furukawa, Y.2
Kato, T.3
Hasegawa, S.4
Yamaoka, Y.5
Nakamura, Y.6
-
73
-
-
0036617270
-
Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma
-
Yagyu R, Hamamoto R, Furukawa Y, Okabe H, Yamamura T, Nakamura Y. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol 2002, 20:1173-8.
-
(2002)
Int J Oncol
, vol.20
, pp. 1173-1178
-
-
Yagyu, R.1
Hamamoto, R.2
Furukawa, Y.3
Okabe, H.4
Yamamura, T.5
Nakamura, Y.6
-
74
-
-
0038070064
-
Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1
-
Okabe H, Satoh S, Furukawa Y. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 2003, 63:3043-8.
-
(2003)
Cancer Res
, vol.63
, pp. 3043-3048
-
-
Okabe, H.1
Satoh, S.2
Furukawa, Y.3
-
75
-
-
18644368855
-
WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation
-
Silva FP, Hamamoto R, Nakamura Y, Furukawa Y. WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation. Neoplasia 2005, 7:348-55.
-
(2005)
Neoplasia
, vol.7
, pp. 348-355
-
-
Silva, F.P.1
Hamamoto, R.2
Nakamura, Y.3
Furukawa, Y.4
-
76
-
-
19544392524
-
Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinoma
-
Iida H, Honda M, Kawai HF. Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinoma. Gut 2005, 54:843-51.
-
(2005)
Gut
, vol.54
, pp. 843-851
-
-
Iida, H.1
Honda, M.2
Kawai, H.F.3
-
78
-
-
0037428667
-
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
-
Midorikawa Y, Ishikawa S, Iwanari H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 2003, 103:455-65.
-
(2003)
Int J Cancer
, vol.103
, pp. 455-465
-
-
Midorikawa, Y.1
Ishikawa, S.2
Iwanari, H.3
-
79
-
-
0035086268
-
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
-
Zhu ZW, Friess H, Wang L. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 2001, 48:558-64.
-
(2001)
Gut
, vol.48
, pp. 558-564
-
-
Zhu, Z.W.1
Friess, H.2
Wang, L.3
-
80
-
-
0038054270
-
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
-
Nakatsura T, Yoshitake Y, Senju S. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun 2003, 306:16-25.
-
(2003)
Biochem Biophys Res Commun
, vol.306
, pp. 16-25
-
-
Nakatsura, T.1
Yoshitake, Y.2
Senju, S.3
-
81
-
-
0038752042
-
Glypican-3 is overexpressed in human hepatocellular carcinoma
-
Sung YK, Hwang SY, Park MK. Glypican-3 is overexpressed in human hepatocellular carcinoma. Cancer Sci 2003, 94:259-62.
-
(2003)
Cancer Sci
, vol.94
, pp. 259-262
-
-
Sung, Y.K.1
Hwang, S.Y.2
Park, M.K.3
-
82
-
-
27944433471
-
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
-
Yamauchi N, Watanabe A, Hishinuma M. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005, 18:1591-8.
-
(2005)
Mod Pathol
, vol.18
, pp. 1591-1598
-
-
Yamauchi, N.1
Watanabe, A.2
Hishinuma, M.3
-
83
-
-
11144357785
-
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma
-
Hippo Y, Watanabe K, Watanabe A. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res 2004, 64:2418-23.
-
(2004)
Cancer Res
, vol.64
, pp. 2418-2423
-
-
Hippo, Y.1
Watanabe, K.2
Watanabe, A.3
-
84
-
-
33646721733
-
Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma
-
Komori H, Nakatsura T, Senju S. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin Cancer Res 2006, 12:2689-97.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2689-2697
-
-
Komori, H.1
Nakatsura, T.2
Senju, S.3
-
85
-
-
0035985214
-
Gene expression patterns in human liver cancers
-
Chen X, Cheung ST, So S. Gene expression patterns in human liver cancers. Mol Biol Cell 2002, 13:1929-39.
-
(2002)
Mol Biol Cell
, vol.13
, pp. 1929-1939
-
-
Chen, X.1
Cheung, S.T.2
So, S.3
-
87
-
-
5644258323
-
Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma
-
Midorikawa Y, Tsutsumi S, Nishimura K. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma. Cancer Res 2004, 64:7263-70.
-
(2004)
Cancer Res
, vol.64
, pp. 7263-7270
-
-
Midorikawa, Y.1
Tsutsumi, S.2
Nishimura, K.3
-
88
-
-
0037096870
-
Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays
-
Bayani J, Brenton JD, Macgregor PF. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res 2002, 62:3466-76.
-
(2002)
Cancer Res
, vol.62
, pp. 3466-3476
-
-
Bayani, J.1
Brenton, J.D.2
Macgregor, P.F.3
-
89
-
-
27944491603
-
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma
-
Patil MA, Gutgemann I, Zhang J. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005, 26:2050-7.
-
(2005)
Carcinogenesis
, vol.26
, pp. 2050-2057
-
-
Patil, M.A.1
Gutgemann, I.2
Zhang, J.3
-
90
-
-
0033545636
-
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1
-
Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 1999, 398:160-5.
-
(1999)
Nature
, vol.398
, pp. 160-165
-
-
Tomoda, K.1
Kubota, Y.2
Kato, J.3
-
91
-
-
33746303268
-
Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma
-
Sy SM, Lai PB, Pang E. Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma. Mod Pathol 2006, 19:1108-16.
-
(2006)
Mod Pathol
, vol.19
, pp. 1108-1116
-
-
Sy, S.M.1
Lai, P.B.2
Pang, E.3
-
92
-
-
34548356776
-
Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells
-
Pang EY, Bai AH, To KF. Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells. Hepatology 2007, 46:436-45.
-
(2007)
Hepatology
, vol.46
, pp. 436-445
-
-
Pang, E.Y.1
Bai, A.H.2
To, K.F.3
-
93
-
-
34047148845
-
Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma
-
Ip WK, Lai PB, Wong NL. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma. Cancer Lett 2007, 250:284-91.
-
(2007)
Cancer Lett
, vol.250
, pp. 284-291
-
-
Ip, W.K.1
Lai, P.B.2
Wong, N.L.3
-
94
-
-
18744371890
-
Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma
-
Sy SM, Wong N, Lai PB, To KF, Johnson PJ. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod Pathol 2005, 18:686-92.
-
(2005)
Mod Pathol
, vol.18
, pp. 686-692
-
-
Sy, S.M.1
Wong, N.2
Lai, P.B.3
To, K.F.4
Johnson, P.J.5
-
95
-
-
36549088147
-
CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma
-
Inagaki Y, Yasui K, Endo M. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma. Cancer Genet Cytogenet 2008, 180:30-6.
-
(2008)
Cancer Genet Cytogenet
, vol.180
, pp. 30-36
-
-
Inagaki, Y.1
Yasui, K.2
Endo, M.3
-
96
-
-
0141591466
-
Expression imbalance map: a new visualization method for detection of mRNA expression imbalance regions
-
Kano M, Nishimura K, Ishikawa S. Expression imbalance map: a new visualization method for detection of mRNA expression imbalance regions. Physiol Genomics 2003, 13:31-46.
-
(2003)
Physiol Genomics
, vol.13
, pp. 31-46
-
-
Kano, M.1
Nishimura, K.2
Ishikawa, S.3
-
97
-
-
0034065509
-
Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment
-
Mitry RR, Sarraf CE, Havlik R, Habib NA. Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment. Hepatology 2000, 31:885-9.
-
(2000)
Hepatology
, vol.31
, pp. 885-889
-
-
Mitry, R.R.1
Sarraf, C.E.2
Havlik, R.3
Habib, N.A.4
-
98
-
-
14444267312
-
P53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus
-
Anderson SC, Johnson DE, Harris MP. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. Clin Cancer Res 1998, 4:1649-59.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 1649-1659
-
-
Anderson, S.C.1
Johnson, D.E.2
Harris, M.P.3
-
99
-
-
24944454988
-
Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers
-
Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 2005, 16:1016-27.
-
(2005)
Hum Gene Ther
, vol.16
, pp. 1016-1027
-
-
Peng, Z.1
-
100
-
-
24944443608
-
Combination therapy with recombinant adenovirus-p53 injection (rAd-p53) via transcatheter hepatic arterial chemoembolization for advanced hepatic carcinoma
-
Guan YS, Sun L, Zhou XP, Li X, He Q, Liu Y. Combination therapy with recombinant adenovirus-p53 injection (rAd-p53) via transcatheter hepatic arterial chemoembolization for advanced hepatic carcinoma. Shijie Huaren Xiaohua Zazhi 2005, 13:125-7.
-
(2005)
Shijie Huaren Xiaohua Zazhi
, vol.13
, pp. 125-127
-
-
Guan, Y.S.1
Sun, L.2
Zhou, X.P.3
Li, X.4
He, Q.5
Liu, Y.6
-
101
-
-
0041854195
-
Antisense overexpression of BMAL2 enhances cell proliferation
-
Yeh CT, Lu SC, Tseng IC. Antisense overexpression of BMAL2 enhances cell proliferation. Oncogene 2003, 22:5306-14.
-
(2003)
Oncogene
, vol.22
, pp. 5306-5314
-
-
Yeh, C.T.1
Lu, S.C.2
Tseng, I.C.3
-
102
-
-
33845290581
-
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma
-
Zhang P, Chan DW, Zhu Y. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma. Clin Cancer Res 2006, 12:6617-25.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6617-6625
-
-
Zhang, P.1
Chan, D.W.2
Zhu, Y.3
-
103
-
-
42249098060
-
Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer
-
Lee SA, Ho C, Roy R. Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer. Hepatology 2008, 47:1200-10.
-
(2008)
Hepatology
, vol.47
, pp. 1200-1210
-
-
Lee, S.A.1
Ho, C.2
Roy, R.3
-
104
-
-
61949261498
-
Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis
-
Midorikawa Y, Yamamoto S, Tsuji S. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 2009, 49:513-22.
-
(2009)
Hepatology
, vol.49
, pp. 513-522
-
-
Midorikawa, Y.1
Yamamoto, S.2
Tsuji, S.3
-
105
-
-
26844435679
-
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
-
Richter TM, Tong BD, Scholnick SB. Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines. Cancer Cell Int 2005, 5:29.
-
(2005)
Cancer Cell Int
, vol.5
, pp. 29
-
-
Richter, T.M.1
Tong, B.D.2
Scholnick, S.B.3
-
106
-
-
0038070458
-
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis
-
Toomes C, Jackson A, Maguire K. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer 2003, 37:132-40.
-
(2003)
Genes Chromosomes Cancer
, vol.37
, pp. 132-140
-
-
Toomes, C.1
Jackson, A.2
Maguire, K.3
-
107
-
-
0032960181
-
Cancer epigenetics comes of age
-
Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999, 21:163-7.
-
(1999)
Nat Genet
, vol.21
, pp. 163-167
-
-
Jones, P.A.1
Laird, P.W.2
-
108
-
-
0345357773
-
Gene silencing in cancer in association with promoter hypermethylation
-
Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-54.
-
(2003)
N Engl J Med
, vol.349
, pp. 2042-2054
-
-
Herman, J.G.1
Baylin, S.B.2
-
109
-
-
38349135680
-
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer
-
Rauch TA, Zhong X, Wu X. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA 2008, 105:252-7.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 252-257
-
-
Rauch, T.A.1
Zhong, X.2
Wu, X.3
-
110
-
-
37549066863
-
Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells
-
Jacinto FV, Ballestar E, Ropero S, Esteller M. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res 2007, 67:11481-6.
-
(2007)
Cancer Res
, vol.67
, pp. 11481-11486
-
-
Jacinto, F.V.1
Ballestar, E.2
Ropero, S.3
Esteller, M.4
-
111
-
-
0041924707
-
Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma
-
Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003, 163:1101-7.
-
(2003)
Am J Pathol
, vol.163
, pp. 1101-1107
-
-
Yang, B.1
Guo, M.2
Herman, J.G.3
Clark, D.P.4
-
112
-
-
40949161396
-
Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma
-
Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008, 47:908-18.
-
(2008)
Hepatology
, vol.47
, pp. 908-918
-
-
Nishida, N.1
Nagasaka, T.2
Nishimura, T.3
Ikai, I.4
Boland, C.R.5
Goel, A.6
-
113
-
-
34248664108
-
Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma
-
Wong CM, Ng YL, Lee JM. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007, 45:1129-38.
-
(2007)
Hepatology
, vol.45
, pp. 1129-1138
-
-
Wong, C.M.1
Ng, Y.L.2
Lee, J.M.3
-
114
-
-
33645294070
-
Oncomirs - microRNAs with a role in cancer
-
Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-69.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
115
-
-
3042767202
-
MicroRNAs: small RNAs with a big role in gene regulation
-
He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-31.
-
(2004)
Nat Rev Genet
, vol.5
, pp. 522-531
-
-
He, L.1
Hannon, G.J.2
-
116
-
-
33646157967
-
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
-
Murakami Y, Yasuda T, Saigo K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-45.
-
(2006)
Oncogene
, vol.25
, pp. 2537-2545
-
-
Murakami, Y.1
Yasuda, T.2
Saigo, K.3
-
117
-
-
46249083024
-
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
-
Ladeiro Y, Couchy G, Balabaud C. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008, 47:1955-63.
-
(2008)
Hepatology
, vol.47
, pp. 1955-1963
-
-
Ladeiro, Y.1
Couchy, G.2
Balabaud, C.3
-
118
-
-
34447117003
-
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma
-
Gramantieri L, Ferracin M, Fornari F. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007, 67:6092-9.
-
(2007)
Cancer Res
, vol.67
, pp. 6092-6099
-
-
Gramantieri, L.1
Ferracin, M.2
Fornari, F.3
-
119
-
-
34547524771
-
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
-
Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-58.
-
(2007)
Gastroenterology
, vol.133
, pp. 647-658
-
-
Meng, F.1
Henson, R.2
Wehbe-Janek, H.3
Ghoshal, K.4
Jacob, S.T.5
Patel, T.6
-
120
-
-
0035097790
-
Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis
-
Kato T, Satoh S, Okabe H. Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia 2001, 3:4-9.
-
(2001)
Neoplasia
, vol.3
, pp. 4-9
-
-
Kato, T.1
Satoh, S.2
Okabe, H.3
-
121
-
-
30144445374
-
Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers
-
Chen Y, Guo Y, Ge X. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. Biochem Biophys Res Commun 2006, 340:758-66.
-
(2006)
Biochem Biophys Res Commun
, vol.340
, pp. 758-766
-
-
Chen, Y.1
Guo, Y.2
Ge, X.3
-
122
-
-
33751042873
-
Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma
-
Guo Y, Chen Y, Ito H. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 2006, 384:51-61.
-
(2006)
Gene
, vol.384
, pp. 51-61
-
-
Guo, Y.1
Chen, Y.2
Ito, H.3
-
123
-
-
43549118215
-
Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF
-
Torisu Y, Watanabe A, Nonaka A. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF. Cancer Sci 2008, 99:1139-46.
-
(2008)
Cancer Sci
, vol.99
, pp. 1139-1146
-
-
Torisu, Y.1
Watanabe, A.2
Nonaka, A.3
|